SFMG Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

SFMG Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,269	Closed	-$262K	–	257
2020 Q4	$262K	Hold	2,269	–	–	0.03%	181
2020 Q3	$221K	Hold	2,269	–	–	0.03%	161
2020 Q2	$278K	Buy	+2,269	New	+$257K	0.04%	128
2020 Q1	–	Sell	-2,268	Closed	-$237K	–	186
2019 Q4	$237K	Sell	2,268 -357	-14%	-$40K	0.03%	147
2019 Q3	$212K	Buy	2,625 +800	+44%	+$121K	0.03%	143
2019 Q2	$304K	Hold	1,825	–	–	0.04%	116
2019 Q1	$308K	Buy	+1,825	New	+$272K	0.04%	112
2018 Q4	–	Sell	-1,825	Closed	-$266K	–	153
2018 Q3	$266K	Sell	1,825 -45	-2%	-$6.49K	0.04%	108
2018 Q2	$261K	Hold	1,870	–	–	0.04%	114
2018 Q1	$211K	Hold	1,870	–	–	0.04%	137
2017 Q4	$247K	Buy	+1,870	New	+$220K	0.04%	120

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFMG Wealth Advisors's GWPH Position: Q1 2021 in Review

SFMG Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,269 shares — an estimated $262K sold.

SFMG Wealth Advisors first reported a position in GWPH in Q4 2017 and held it in 11 quarters. The position peaked at $308K in Q1 2019. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

SFMG Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
SFMG Wealth Advisors sold 2,269 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $262K.
SFMG Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 11 quarters.
SFMG Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $308K in Q1 2019.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on SFMG Wealth Advisors's 13F filing for Q1 2021, filed 3 May 2021.